Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Old mystery solved, revealing origin of regulatory T cells that 'police' and protect the body

Old mystery solved, revealing origin of regulatory T cells that 'police' and protect the body

October 13, 2005

HOUSTON-More than 150 years after the discovery of Hassall's corpuscles in 1849, the function of these round blobs of cells in the human thymus gland has now been explained. The answer, in turn, ends an intense hunt for the origin of regulatory T cells that has been under way for years.

Reporting in the Aug. 25 issue of Nature, researchers at The University of Texas M. D. Anderson Cancer Center found that Hassall's corpuscles produce chemical signals that instruct dendritic cells in the thymus to induce development of these regulatory T cells-the critically important immune system cells that patrol the body looking for "bad' T cells that can produce autoimmune disease.




"These mysterious little structures in the thymus are responsible for producing the T cell policemen that our bodies depend so heavily on," says the study's lead author, Yong-Jun Liu, M.D., Ph.D., professor and chair of the Department of Immunology. "It is a very smart system that evolved during evolution to efficiently keep the immune system in check."

The thymus functions like a school to educate immature immune system "T" (for thymus) cells. T cells are white blood cells that play vital roles in the immune system, including the identification of specific foreign "antigens" in the body (toxins, bacteria, viruses and other invading cells) and the activation and deactivation of other immune cells.

A chief function of the thymus is the selection of the T cell repertoire the immune system uses to combat infections-a process known as "clonal selection theory" that earned the researchers who discovered it a Nobel Prize in 1960. This involves the "positive selection" of T cells that are non self-reactive and the elimination, through "negative selection," of T cells that are self-reactive or autoreactive. If allowed outside of the thymus gland, these autoreactive T cells would produce a harmful immune response against the body's own tissues, so the immune system flags "dendritic" cells within the thymus to eliminate these bad cells. T cells that pass both levels of selection are then released into the bloodstream to perform vital immune functions.

"It was believed that the only way to induce what is known as central tolerance was by deleting harmful T cells during development," says Liu.

But scientists now know that not all the "bad" T cells are destroyed through negative selection. Some autoreactive T cells escape the thymic censorship process and are released into the circulation. For that reason, researchers searched for additional mechanisms that exist in the blood and lymph system outside of the thymus to take care of these bad actors-which led to the discovery of regulatory T cells. These special T cells act like policemen to scour out dangerous T cells and suppress activation of the immune system, and thus maintain tolerance to self.

A major question in immunology was how regulatory T cells are developed in the thymus.

In 2002, in Nature Immunology, Liu and his research team revealed the existence of the chemical signal TSLP (thymic stromal lymphopoietin) that activates dendritic cells in the thymus. In 2004, they reported, also in Nature Immunology, that epithelial cells within Hassall's corpuscles express TSLP.

In this study, using human thymus tissue taken during cardiac surgery in children-tissue that otherwise would have been discarded " the researchers isolated different components of thymic cells, and reconstituted them in test tubes. They then conducted numerous experiments over several years, looking at different stages of T cell development and activation of dendritic cells.

They found that Hassall's corpuscles produce chemical signals that direct a specialized group of dendritic cells to turn some of the bad T cells into "good cop" regulatory T cells.

This means that the thymus is providing central tolerance not only through clonal deletion as was previously proposed by the clonal selection theory, but also through clonal conversion, as demonstrated in the current study.

The findings open new avenues in which to further explore the function of regulatory T cells in autoimmune disease and in cancer, the researchers say.

For example, mice experiments show that if regulatory T cells are destroyed, the animals will develop arthritis and other autoimmune diseases. So, if scientists can determine precisely how Hassall's corpuscles and dendritic cells turn T cells into regulatory T cells, it may be possible to "convert" the errant T cells that promote an immune response in tissue into regulatory T cells, thus suppressing such disorders, Liu says.

Similarly, the discovery may help provide clues as to how cancer cells use regulatory T cells to work on their behalf, he says. One of the beneficial roles of regulatory T cells is to suppress the immune system (thus inactivating the damage caused by errant T cells), but "in cancer patients, regulatory T cells become troublemakers, because they suppress any natural reaction the immune system might have mounted to fight the cancer," Liu says.

"It may be that cancer is converting normal T cells into regulatory T cells to protect itself, and once we know the molecular language by which Hassall's corpuscles and dendritic cells induce regulatory T cells, then we might understand how tumor cells also do this," he says.

University of Texas M. D. Anderson Cancer Center



Related Regulatory T Cells Current Events and Regulatory T Cells News Articles Regulatory T Cells Current Events and Regulatory T Cells News RSS Regulatory T Cells Current Events and Regulatory T Cells News RSS
Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards -- the 2009 NIH Director's Pioneer Award.

Promising new target emerges for autoimmune diseases
University of Michigan scientists say they have uncovered a fundamentally new mechanism that holds in check aggressive immune cells that can attack the body's own cells.

Taking the Needle's Sting Out of Diabetes
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials.

Common allergy drug reduces obesity and diabetes in mice
Crack open the latest medical textbook to the chapter on type 2, or adult-onset, diabetes, and you'll be hard pressed to find the term "immunology" anywhere.

Mouse experiments shed light on age effects in arthritis
Older mice are more susceptible to proteoglycan-induced arthritis (PGIA). Researchers writing in BioMed Central's open access journal Immunity & Ageing have shown, for the first time, that young mice are completely resistant, but become fully susceptible to the disease with age.

TB -- hiding in plain sight
Current research suggests that Mycobacterium tuberculosis can evade the immune response.

When acute hepatitis develops into chronic hepatitis
To achieve this, Carlos A. Guzmán, Head of the "Vaccinology and Applied Microbiology" working group and Robert Geffers, Head of the "Gene Expression Analysis" platform, examined the incidence and species of special defence cells, T helper cells, along with their role in the development of the disease in conjunction with their Indian colleagues.

Hodgkin lymphoma -- new characteristics discovered
Researchers are still discovering new characteristics of Hodgkin lymphoma, a common form of cancer of the lymphatic system. The malignant cells are derived from white blood cells (B cells), but have lost a considerable part of the B cell-specific gene expression pattern.

Vaccine against HER2-positive breast cancer offers complete protection in lab
Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice - even cancers resistant to current anti-HER2 therapy - without any toxicity.

Bone marrow stem cells may help control inflammatory bowel disease
Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model.
More Regulatory T Cells Current Events and Regulatory T Cells News Articles
Regulatory T Cells in Inflammation (Progress in Inflammation Research)

Regulatory T Cells in Inflammation (Progress in Inflammation Research)
by Leonie S. Taams (Editor), Arne N. Akbar (Editor), Marca H.M. Wauben (Editor)

Scientific interest in regulatory T cells has revived during the last decade. Initially described in the early seventies as suppressor T cells, the concept of suppressor/regulatory T cells went through turbulent times during the eighties when molecular analysis failed to identify putative suppressor genes. The constructive and elegant cellular experiments on regulatory T cells during the nineties, initiated by Shimon Sakaguchi and co-workers, however have brought these cells back into the limelight. Nowadays, regulatory T cells are regarded as essential components of the immune system, and several different subsets of regulatory T cells have been described. Considerable regulatory function has been attributed to the CD4+CD25+ T cell subset. These cells act by suppressing adaptive and...

Regulatory T Cells and Clinical Application

Regulatory T Cells and Clinical Application
by Shuiping Jiang (Author), Shuiping Jiang (Editor)

The immune system reacts vigorously to foreign invaders such as viruses, bacteria, protozoa, and parasites, and yet shows unresponsiveness to our own proteins. Immune tolerance to self-proteins is paramount to prevent the development of autoimmune disease. In the past decade, several types of T lymphocytes in the immune system have been discovered to function as regulatory cells to suppress unwanted immune responses to self-proteins, leading to the protection of autoimmunity. Furthermore, regulatory T cells also protect us from the development of asthma allergy, and prevent organ transplantation rejection.

Regulatory T Cells and Clinical Application provides a comprehensive view of all types of regulatory T cells described so far in the literature. By thoroughly...

CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential (Current Topics in Microbiology and Immunology)

CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential (Current Topics in Microbiology and Immunology)
by B. Kyewski (Editor), Elisabeth Suri-Payer (Editor)

The vertebrate immune system defends the organism against invading pathogens while at the same time being self-tolerant to the body's own constituents thus preserving its integrity. Multiple mechanisms act in concert to ensure self-tolerance. Additional tolerance mechanisms, collectively referred to as dominant tolerance is by now firmly established. It will offer new conceptual insights and hopefully new tools for the sucessful treatment of autoimmune diseases, improved cancer immunotherapy and transplant survival.

Molecular mechanisms of T cell tolerance: Regualtion of FOXP3 expression: a key transcription factor for  regulatory T cells

Molecular mechanisms of T cell tolerance: Regualtion of FOXP3 expression: a key transcription factor for regulatory T cells
by Pierre-Yves Mantel (Author)

Regulatory T cells (Tregs) play an important role in immune homeostasis, by maintaining tolerance to self-antigens and allergens as well as by limiting inflammatory tissue damage during chronic infections. Humans or mice lacking the Treg-associated transcription factor FOXP3 develop severe features of autoimmunity and allergy. Ectopic FOXP3 expression endows non-regulatory T cells with many of the hallmarks of regulatory T cells and transgenic reporter mice carrying a FOXP3-GFP indicated that FOXP3 expression correlates with suppressive T cells. Although Tregs can be generated in the thymus, their induction is observed in the periphery. The molecular mechanisms leading to Tregs generation in the periphery are still poorly understood. To gain insight into...

Parameters of intrathymic regulatory T cell differentiation: Thymic Treg development does not require a dedicated antigen-presenting cell type but is under ... cell-intrinsic control

Parameters of intrathymic regulatory T cell differentiation: Thymic Treg development does not require a dedicated antigen-presenting cell type but is under ... cell-intrinsic control
by Gerald Wirnsberger (Author)

The majority of regulatory T cells (Tregs) are believed to be of thymic origin. It has been hypothesized that this may result from unique intrathymic environmental cues, possibly requiring a dedicated antigen presenting cell (APC). However, T cell intrinsic developmental regulation of the susceptibility to Treg differentiation remains a mutually non-exclusive scenario. We found that upon exposure of monoclonal T cells of sequential developmental stages to a thymic microenvironment expressing cognate antigen, the efficiency of Treg induction inversely correlated with progressive maturation. In support of quantitative but not qualitative features of external cues being critical, thymic epithelial cells as well as different thymic dendritic cell (DC)-subtypes efficiently induced Treg...

Ovarian Cancer: State of the Art and Future Directions in Translational Research (Advances in Experimental Medicine and Biology)

Ovarian Cancer: State of the Art and Future Directions in Translational Research (Advances in Experimental Medicine and Biology)
by George Coukos (Author), George Coukos (Editor), Andrew Berchuck (Editor), Robert Ozols (Editor)

Aegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for Biomedical Research Academy of Athens. The board both invites and approves unsolicited proposals for Conferences in all fields of Science, Engineering, Arts, and Humanities. The purpose of the Conferences is to bring together individuals with common interests to examine the emerging and most advanced aspects of their particular field.

The Symposium on Ovarian Cancer: State of the Art and Future Directions intends to bring together international experts interested in the development of...

  Legal and regulatory issues for onsite fuel cell planning by gas utilities
by John T Nimmons (Author)



© 2009 BrightSurf.com